Literature DB >> 20219906

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.

Yuushi Okumura1, Etsuhisa Takahashi, Mihiro Yano, Masanobu Ohuchi, Tomo Daidoji, Takaaki Nakaya, Eva Böttcher, Wolfgang Garten, Hans-Dieter Klenk, Hiroshi Kido.   

Abstract

Host cellular proteases induce influenza virus entry into cells by cleaving the viral surface envelope glycoprotein hemagglutinin (HA). However, details on the cellular proteases involved in this event are not fully available. We report here that ubiquitous type II transmembrane serine proteases, MSPL and its splice variant TMPRSS13, are novel candidates for proteases processing HA proteins of highly pathogenic avian influenza (HPAI) viruses, apart from the previously identified furin and proprotein convertases 5 and 6. HAs from all HPAI virus H5 and H7 strains have one of two cleavage site motifs, the R-X-K/R-R motif with R at position P4 and the K-K/R-K/T-R motif with K at position P4. In studies of synthetic 14-residue HPAI virus HA peptides with these cleavage site motifs, furin preferentially cleaved only HA peptides with the R-K-K-R motif in the presence of calcium and not peptides with the other motif, whereas MSPL and TMPRSS13 cleaved both types of HA peptides (those with the R/K-K-K-R motif) efficiently in the absence of calcium. Full-length recombinant HPAI virus HA with the K-K-K-R cleavage motif exhibited poor susceptibility to cleavage in the absence of MSPL or TMPRSS13 and the presence of furin in infected cells, but it was converted to mature HA subunits in transfected cells expressing MSPL or TMPRSS13, with membrane-fused giant-cell formation. This conversion and membrane fusion were suppressed by inhibitors of MSPL and TMPRSS13. Furthermore, infection with and multiplication of genetically modified live HPAI virus A/Crow/Kyoto/53/2004 (H5N1) with the K-K-K-R cleavage site motif were detected only in MSPL- and TMPRSS13-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219906      PMCID: PMC2863848          DOI: 10.1128/JVI.02605-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A protein-based therapeutic for human cytomegalovirus infection.

Authors:  F Jean; L Thomas; S S Molloy; G Liu; M A Jarvis; J A Nelson; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.

Authors:  M Murakami; T Towatari; M Ohuchi; M Shiota; M Akao; Y Okumura; M A Parry; H Kido
Journal:  Eur J Biochem       Date:  2001-05

Review 3.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

4.  Proteolytic activation of the 1918 influenza virus hemagglutinin.

Authors:  Chawaree Chaipan; Darwyn Kobasa; Stephanie Bertram; Ilona Glowacka; Imke Steffen; Theodros Solomon Tsegaye; Makoto Takeda; Thomas H Bugge; Semi Kim; Youngwoo Park; Andrea Marzi; Stefan Pöhlmann
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

5.  Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.

Authors:  C F Basler; A H Reid; J K Dybing; T A Janczewski; T G Fanning; H Zheng; M Salvatore; M L Perdue; D E Swayne; A García-Sastre; P Palese; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung.

Authors:  D R Kim; S Sharmin; M Inoue; H Kido
Journal:  Biochim Biophys Acta       Date:  2001-03-19

7.  Identification of ectopic anionic trypsin I in rat lungs potentiating pneumotropic virus infectivity and increased enzyme level after virus infection.

Authors:  Takae Towatari; Mikiko Ide; Kumiko Ohba; Yuusuke Chiba; Meiko Murakami; Mayumi Shiota; Miki Kawachi; Hiroshi Yamada; Hiroshi Kido
Journal:  Eur J Biochem       Date:  2002-05

8.  Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides.

Authors:  A Basak; M Zhong; J S Munzer; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

9.  Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.

Authors:  Oleg P Zhirnov; Mine R Ikizler; Peter F Wright
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.

Authors:  Sarah Netzel-Arnett; John D Hooper; Roman Szabo; Edwin L Madison; James P Quigley; Thomas H Bugge; Toni M Antalis
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

View more
  39 in total

1.  Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Authors:  Andrew S Murray; Fausto A Varela; Thomas E Hyland; Andrew J Schoenbeck; Jordan M White; Lauren M Tanabe; Sokol V Todi; Karin List
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

2.  DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.

Authors:  Pawel Zmora; Paulina Blazejewska; Anna-Sophie Moldenhauer; Kathrin Welsch; Inga Nehlmeier; Qingyu Wu; Heike Schneider; Stefan Pöhlmann; Stephanie Bertram
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.

Authors:  Eva Böttcher-Friebertshäuser; David A Stein; Hans-Dieter Klenk; Wolfgang Garten
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Impact of chicken-origin cells on adaptation of a low pathogenic influenza virus.

Authors:  Shahla Shahsavandi; Mohammad Majid Ebrahimi; Ashraf Mohammadi; Nima Zarrin Lebas
Journal:  Cytotechnology       Date:  2012-09-26       Impact factor: 2.058

5.  Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.

Authors:  Miyuki Kawase; Kazuya Shirato; Lia van der Hoek; Fumihiro Taguchi; Shutoku Matsuyama
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

6.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

7.  In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses.

Authors:  Sina Soleimani; Omid Madadgar; Shahla Shahsavandi; Homayoon Mahravani; Mohsen Lotfi
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 8.  Antiviral strategies against influenza virus: towards new therapeutic approaches.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulio Nannetti; Chiara Compagnin; Giorgio Palù
Journal:  Cell Mol Life Sci       Date:  2014-04-04       Impact factor: 9.261

9.  Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.

Authors:  Joanna Baron; Carolin Tarnow; Deborah Mayoli-Nüssle; Eva Schilling; Daniela Meyer; Maya Hammami; Folker Schwalm; Torsten Steinmetzer; Yi Guan; Wolfgang Garten; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

10.  Novel hemagglutinin-based influenza virus inhibitors.

Authors:  Xintian Shen; Xuanxuan Zhang; Shuwen Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.